(Q51798471)

English

Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance.

scientific article published on 21 November 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

Results from an inter-laboratory comparison of pneumococcal serotype-specific IgG measurement and critical parameters that affect assay performance. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

author name string

A Balloch

1

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

P V Licciardi

2

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

A Leach

3

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

A Nurkka

4

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

M L K Tang

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

language of work or name

0 references

publication date

21 November 2009

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

28

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

5

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

1333-1340

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

Magnitude of the problem of childhood pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Pneumococcal vaccines: an update on current strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Pathogenesis of Pneumococcal Infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Mechanisms of host defense against infection with Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Interleukin-17A mediates acquired immunity to pneumococcal colonization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Differential regulation of protein- and polysaccharide-specific Ig isotype production in vivo in response to intact Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Genetic basis for the new pneumococcal serotype, 6C.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Comparison of the human immune response to conjugate and polysaccharide pneumococcal vaccination using a reconstituted SCID mouse model.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Thymus-independent and thymus-dependent responses to polysaccharide antigens

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Accessory cell defect in unresponsiveness of neonates and aged to polysaccharide vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

The effect of T cell independent and cross-reactive antigen on the immune response to pneumococcal conjugate vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Immune responses to polysaccharides: lessons from humans and mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Specificity of human antibodies reactive with pneumococcal C polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Are the enzyme immunoassays for antibodies to pneumococcal capsular polysaccharides serotype specific?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Critical differences between pneumococcal polysaccharide enzyme-linked immunosorbent assays with and without 22F inhibition at low antibody concentrations in pediatric sera

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Statistical methods for assessing agreement between two methods of clinical measurement

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

A concordance correlation coefficient to evaluate reproducibility

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

THE FORMATION OF ANTIBODIES IN MAN AFTER INJECTION OF PNEUMOCOCCAL POLYSACCHARIDES.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Anticapsular Serum Antibody Concentration and Protection against Pneumococcal Colonization among Children Vaccinated with 7-Valent Pneumococcal Conjugate Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Effects of absorption with pneumococcal type 22F polysaccharide on maternal, cord blood, and infant immunoglobulin G antipneumococcal polysaccharide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Method for simultaneous measurement of antibodies to 23 pneumococcal capsular polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Enzyme-linked immunosorbent assay for measuring antibodies to pneumococcal polysaccharides for the PNEUMOVAX 23 vaccine: assay operating characteristics and correlation to the WHO international assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Purification and structure characterization of the active component in the pneumococcal 22F polysaccharide capsule used for adsorption in pneumococcal enzyme-linked immunosorbent assays.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Social mixing with other children during infancy enhances antibody response to a pneumococcal conjugate vaccine in early childhood.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

ELISA for the detection of anticardiolipin antibodies. High specificity based on the use of adult bovine serum as buffer and systematic subtraction of non-specific binding

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Correlates of immunity for pneumococcal conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Minimum protective serum concentrations of pneumococcal anti-capsular antibodies in infant rats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

B- and T-cell immune responses to pneumococcal conjugate vaccines: divergence between carrier- and polysaccharide-specific immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2009.11.011

7 January 2021

Identifiers

10.1016/J.VACCINE.2009.11.011

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 April 2018

http://europepmc.org/abstract/MED/19932671

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51798471&oldid=1483210746"